# Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.

> **NCT00394056** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 26 (actual)

## Conditions studied

- Tinnitus

## Interventions

- **DRUG:** Vestipitant
- **DRUG:** Vestipitant + Paroxetine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00394056
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2016-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00394056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00394056, "Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss.". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00394056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*